ARTAN Bio retweeted
lnkd.in/p/gDsdt4mA
Getting mainstream visibility is how we level up DeSci! Happy to do my part in a way that helps the ecosystem! Will shine a light on $vitarna and how tokenizing science can be win-win. @vitarnabio @vitadao @Molecule_sci @BioProtocol @paulkhls @artan_bio
ARTAN Bio retweeted
Happy to share that @artan_bio just closed a $1M seed round — to advance our suppressor tRNA platform from preclinical toward first-in-human studies for age-related disease. Excited to build this with @Mykalt45 and @BTC_Biotech_guy !
prnewswire.com/news-releases…
ARTAN Bio retweeted
Check out the cool things we’re working on at @artan_bio for all stakeholders including $vitarna token holders! Excited for the future. Biotech and crypto are unlocking new opportunities! @vitarnabio @vitadao @Molecule_sci
We will be making major updates to the @artan_bio and @vitarnabio websites over the next few weeks. We will be more active in communicating our progress as we work to advance our therapeutic assets to the clinic over the next year.
Our $VITARNA partners at @vitadao have plans to make the token more accessible by bridging to additional chains and by creating straightforward buying mechanisms for crypto-naive users who want to support the project. We are also working with our $VITARNA partners to build organic demand for the token. This will be related to our VITABEAUTY aging cosmetics launching in 2027. More details to come over the coming weeks.
The ARTAN Bio founders (@Mykalt45, & @aschwartzphd) and I are working diligently to deliver on the opportunity that the $VITARNA community has helped to create. Thank you for your support!
We just closed a $1M seed round led by our co-founder @Mykalt45 , fresh off building CrossBridge Bio through its acquisition by Eli Lilly — fuel to push our suppressor tRNA platform from preclinical toward first-in-human.
prnewswire.com/news-releases…
ARTAN Bio retweeted
New science out that supports Artan-102:
Aging & cancer both share a hidden mutational clock: CGA→UGA nonsense mutations driven by CpG deamination. 🧬
With the support of the DeSci community & $VitaRNA token holders, we’re developing Artan-102 codon suppressors to fight back. 🚀
ARTAN Bio retweeted
New @Nature study maps how our brains age at single-cell resolution. 🚨
Housekeeping genes (ribosome, metabolism, transport) are hit hardest, silenced by accumulated DNA damage + premature stop codons. @Molecule_dao @paulkhls @vita_dao @artan_bio
Quick update, doing a site visit today at Lonza. They’re currently working on optimizing manufacturing for Artan-102. Will capture content!
Amazing opportunity for vitarna token holders!
What if a single therapy could validate the entire aging thesis?
Michael Torres explains how $VITARNA is built to hit a huge disease target, and open new doors in longevity.
Watch the full episode here:
youtu.be/GBrmoFELIJc
7
674
Doing big stuff here! Real science, real aging drug!
cell.com/cell/abstract/S0092…
More to come! Learn more at vitarna.xyz. Join us as we disrupt aging!
Check out vitarna.xyz / molecule.xyz to learn more about what we’re doing. We’re also actively raising from traditional investors who are interested in pursuing a novel longevity therapeutic! Crypto may be too slow for us! We’re that fast!
🧵 1/ Why does the new SMaHT atlas of somatic mutations matter for #Artan102, our nonsense codon suppression therapy?
It’s all about CGA codons, nonsense mutations, and aging. 🔬👇
If you want to see how DeSci + Crypto + Longevity drug development are all coming together then check out our project page at molecule.xyz/ipts/VITARNA.
The project update has the latest non-con with the latest data.
@vita_dao @BioProtocol @Molecule_dao
Want to learn more about the aging science we’re addressing with $vitarna & @vitarnabio? Check out the video below. Artan-102 backed by @vitadao and @Molecule_dao is leveraging the crypto community to fund drug development in a whole new way. Learn more at vitarna.xyz
ARTAN Bio retweeted
Reach out to me or @BoostVC if we have not invested in you yet and your are on this market map.
Short Academia. Buy DeSci.
PHDegens 🤝 DeSci Season.
A list to follow along: teapawt.net/i/lists/18752112497907…
ARTAN Bio retweeted
Excited to see this program continue moving forward. Working to check off all the boxes…Novel IP, cool biology, and a data set that could support IND-enabling studies. Working hard to create value for everyone, including token holders! Join us! @artan_bio @vitarnabio
🧬 VitaRNA: $1M Follow-on Fundraise Launched!
First Tokenized Gene Therapy Project Preparing for Animal Studies
Vision: Develop targeted gene therapies addressing key aspects of aging through nonsense mutation suppression. Built with community support, democratizing access to cutting-edge longevity research.
Major October 2024 Milestone: Validated two promising drug candidates from 15 initial prototypes, showing effective suppression of arginine nonsense mutations in P53 cancer cell lines.
Detailed 2025 Roadmap: Q1:
• $1M Fundraise
• Begin ARTAN-102 scaled manufacturing
Q2-Q3:
• Start disease model animal studies
• Present at scientific conferences
The $1M raise enables:
• GLP-toxicology studies
• Biomarker validation
• Safety testing
• IP portfolio expansion
• Regulatory strategy development
Fundraise terms:
• 9-month lock-up
• 50% discount
• 31-day duration
Pioneer in DeSci Funding:
• Initial $91k VitaDAO funding via IP-NFT
• Raised $300k via IP tokenization
• Community-driven governance
• Transparent research priorities
• Decentralized IP ownership
Team: Led by top biotech experts with a proven track record in advancing drug development to clinical trials. ( @Mykalt45 & @aschwartzphd )
Join our journey:
• Visit vitarna.xyz
• Join community: t.me/vitarna
• VitaRNA on CoinGecko: coingecko.com/en/coins/vitar…
Support the VitaRNA Fundraise 👇 mint.molecule.to/ipnft/28/cr…
ARTAN Bio retweeted
Those C -> T transitions can be quite deleterious! This is part of what we’re addressing with @artan_bio and $vitarna. Keep an eye out!
In a Review now available online, Natalie Ngoi, David Gallo, Carlos Torrado, Mirella Nardo, Daniel Durocher & Tim Yap provide an updated and comprehensive overview of the role of systhetic lethal strategies in cancer therapy nature.com/articles/s41571-0…
ARTAN Bio retweeted
Quick update…we’ve officially signed a quote to do our first preliminary safety and PK study in mice with Artan-102!
Don’t know the start date yet, but I’m hoping the in-life portion is done before Christmas!
Exciting to see this project moving forward! Vitarna.xyz #DeSci
















